Reimbursement is not an issue for basic cancer tests, but questions surround the payment and guidelines for more cutting-edge medical innovations, said Bruce Quinn, MD, PhD, a consultant at Foley Hoag. He added that the role of employers in health management is not changing as quickly as we may think.
Reimbursement is not an issue for basic cancer tests, but questions surround the payment and guidelines for more cutting-edge medical innovations, said Bruce Quinn, MD, PhD, a consultant at Foley Hoag. He added that the role of employers in health management is not changing as quickly as we may think.
Transcript (slightly modified)
Personalized medicine is still in its infancy: what are some of the challenges so far with reimbursement?
Well, as far as challenges to reimbursement, I think that sometimes they get exaggerated. I think that cancer patients for example that have breast cancer, lung cancer, colon cancer, they get the basic tests that they need. Melanoma, you get a BRAF test; colon cancer, you get the right test; and so on. So the question isn’t whether you’re getting the basic tests, the question is what’s the cutting edge and how will that be reimbursed.
And the cutting edge for innovative medical technologies has always been sort of a war zone for decades, or longer. There’ll always be a time when something’s available but it’s not widely covered yet, or it’s not fully caught up in guidelines. That’s really where the cutting edge is.
How does the implementation of the public insurance exchanges and the increasing use of private exchanges change the employer’s role in managing health?
I think that the increasing use of public exchanges and private exchanges is actually not changing the employer’s role that fast.
The things that employers look for, it’s efficiency of the health plan. You may see things like a $200 rebate when you have a gym membership, or you get some incentives to be in a quit smoking or a lose weight program, but those are really on the fringe of healthcare. I mean, they’re important, but you don’t need a 10,000-person health plan in order to have a rebate on your gym memberships. So I think in a lot of ways, the quality coming from the health plan is not moving that fast.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More